http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_be73887deab83b2881c389cdd98e6d7f
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Monteiro |
| name | Alvaro N.A Monteiro Alvaro N.A. Monteiro Alvaro NA Monteiro |
| given-name | Alvaro N.A. Alvaro N.A Alvaro NA |
| organization-name | Division of Population Sciences; Moffitt Cancer Center; Tampa; Florida Laboratory of Molecular Oncology, The Rockefeller University, New York, NY 10021, USA. Tel.: ; Fax: ; E-mail: monteia@rockvax.rockefeller.edu Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA Authors' Affiliations: 1Abramson Cancer Center, Departments of 2Medicine, 3Cancer Biology, and 4Pathology and Laboratory Medicine, 5Basser Research Center for BRCA1/2, Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania; 6Vironika, Philadelphia, Pennsylvania; 7Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital; 8Program in Cancer Genetics, Departments of Oncology and Human Genetics, and 9Research Institute, McGill University Health Centre, McGill University, Montreal, Quebec, Canada; 10Department of Medical Genetics, University of Cambridge, Cambridge; and 11Ferguson Smith Centre for Clinical Genetics, Yorkhill, Glasgow, United Kingdom; 12Cancer Epidemiology Program, H. Lee Moffitt Cancer Center, Tampa, Florida; 13Cancer Genetic Risk Assessment Program, Bryan Hemming Cancer Care Center, San Francisco, California; 14Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; 15Huntsman Cancer Institute and Department of Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA Authors' Affiliations: 1Department of Statistical Science, Duke University, Durham, North Carolina; 2Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; Departments of 3Dermatology and 4Oncological Sciences, University of Utah School of Medicine, Salt Lake City, Utah; and 5Risk Assessment, Detection, and Intervention Program, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida. Division of Population Sciences, Department of Health Outcomes and Behavior Moffitt Cancer Center Tampa Florida 1Risk Assessment, Detection, and Intervention Program, and Cancer Epidemiology Program, Division of Population Sciences, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA, Authors' Affiliations: 1Department of Biochemistry, School of Systems Molecular Medicine, University of Alberta, Edmonton, Alberta, Canada; 2National Institute of Environmental Health Sciences, Durham, North Carolina; 3Risk Assessment, Detection, and Intervention Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida; and 4Molecular Biology Program, Institute of Biophysics Carlos Chagas Fo., Federal University of Rio de Janeiro, Rio de Janeiro, Brazil Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida 33612, United States Cancer Epidemiology Program; H. Lee Moffitt Cancer Center; Tampa Florida Authors' Affiliations: 1Cancer Epidemiology Program, Division of Population Sciences, Departments of 2Interdisciplinary Oncology, 3Biostatistics, 4Biomedical Informatics, 5Women's Oncology, and 6Health Outcomes and Behavior, Moffitt Cancer Center; 7Department of Epidemiology and Biostatistics, College of Public Health, and 8Pediatrics Epidemiology Center, College of Medicine, University of South Florida, Tampa, Florida; 9Case Comprehensive Cancer Center, Case School of Medicine, Cleveland, Ohio; 10Massachusetts General Hospital; 11Obstetrics and Gynecology Epidemiology Center, Brigham Women's Hospital, Boston, Massachusetts; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, Maryland; Departments of 13Laboratory Medicine and Pathology and 14Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota; 15Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre; 16Department of Gynaecologi 84Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida. 1Risk Assessment, Detection, and Intervention Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida and H. Lee Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA. |
Incoming Links
Total number of triples: 76.